Scripps Research Logo

Frank Chisari, M.D.

Professor
Head
Laboratory of Experimental Virology
Department of Immunology and Microbial Science
California Campus
Laboratory Website
fchisari@scripps.edu
(858) 784-8228

Scripps Research Joint Appointments

Professor, Department of Immunology and Microbial Science
Faculty, Kellogg School of Science and Technology

Research Focus

Immunobiology and Pathogenesis of
Hepatitis B and C Virus Infection


The outcome of noncytolytic viral infections is largely determined by the cellular immune response. Our laboratory focusses on the host-virus interactions that determine the outcome of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Using a combination of real time viral dynamics and quantitative functional T cell analysis, we have demonstrated a direct relationship between viral clearance and the vigor, kinetics and homing potential of the antiviral T cell response to HBV and HCV, the rate with which they spread after inoculation and their ability to escape immune recognition. In addition, we have shown that there is a third effector limb in the immune response besides antibody neutralization and T cell-mediated destruction of infected cells: i.e. T cells also secrete antiviral cytokines that can purge viruses from infected cells without killing them. Currently we are applying genome-wide expression profiling to define the intracellular antiviral effector pathways that are triggered by these cytokines; biochemical, biophysical and molecular approaches to identify the points in the life cycles of these viruses that are targeted by these antiviral cytokines; and molecular immunological strategies to determine the mechanisms deployed by the viruses to defeat their antiviral effects.

Education

M.D., Medicine, Weill Cornell Medical College, New York, New York, 1968
A.B., Biology, Fordham University, New York, New York, 1963

Professional Experience

Training -
Anatomic Pathology: Fellow, Cornell University Medical College, New York 1966-1967; Fellow, Mayo Clinic, Rochester, Minnesota 1969-1970.
Internal Medicine: Intern, The New York Hospital-Cornell University Medical Center,New York, New York 1968-1969. Resident, Mary Hitchcock Memorial Hospital, Dartmouth Medical School, Hanover, New Hampshire 1972-1973.
Immunopathology: Staff Associate, Laboratory of Pathology, National Institutes of Health, Bethesda, Maryland 1970-72 Research Fellow, Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California  1973-1975.
Molecular Biology: Fogarty Scholar, Unite de Recombinaison et Expression Genetique, Institut Pasteur, Paris, France  1983-1984.
Employment -
1975-1981:  Assistant Professor, Departments of Molecular Immunology and Clinical Research, Scripps Clinic and Research Foundation, La Jolla, California
1981 - 1988: Associate Professor, Department of Basic and Clinical Research, Research Institute of Scripps Clinic, La Jolla, California
1989-2004: Director, General Clinical Research Center, The Scripps Research Institute, La Jolla, California
1988-2008: Professor and Head, Division of Experimental Pathology, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California
2008-Present: Professor and Head, Laboratory of Experimental Virology, Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California

Awards & Professional Activities

NIH MERIT Award, 1990-2000, Member, Association of American Physicians, 1992, Fellow, American Association for the Advancement of Science, 1996-present, Ernst Jung Prize in Medicine ,1997, Rous-Whipple Award, American Society for Investigative Pathology, 1999, Distinguished Advisory Committee, UCSD Cancer Center, 2000-present Review Panel, Int'l Research Scholars Program, Howard Hughes Med. Inst., 2000-present Scientific Advisory Board, Center for the Study of HCV, Rockefeller Univ., 2000-present Board of Scientific Councilors, NIAID, NIH, 2001 Blue Ribbon Panel on Bioterrorism Research, NIAID, NIH, 2002 Expert Panel on Immunity and Biodefense, NIAID, NIH, 2002 Fellow, American Academy of Microbiology, 2002 Member, National Academy of Sciences, 2002 Member, Institute of Medicine, National Academy of Sciences, 2003 Distinguished Alumnus Award, Weill-Cornell University Medical College, 2004, ISI Highly Cited Researcher, 2006-present.

Selected References

                          SELECTED PUBLICATIONS SINCE 2005

 

Dreux M, Garaigorta U, Boyd B, Décembre E, Chung J, Whitten-Bauer C, Wieland S, Chisari FV. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe. 2012 Oct 18;12(4):558-70. doi: 10.1016/j.chom.2012.08.010. PubMed PMID: 23084922; PubMed Central PMCID: PMC3479672.

Garaigorta U, Heim MH, Boyd B, Wieland S, Chisari FV. Hepatitis C virus (HCV) induces formation of stress granules whose proteins regulate HCV RNA replication and virus assembly and egress. J Virol. 2012 Oct;86(20):11043-56. Epub 2012 Aug 1. PubMed PMID: 22855484; PubMed Central PMCID: PMC3457181.

Sitia G, Aiolfi R, Di Lucia P, Mainetti M, Fiocchi A, Mingozzi F, Esposito A, Ruggeri ZM, Chisari FV, Iannacone M, Guidotti LG. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):E2165-72. doi: 10.1073/pnas.1209182109. Epub 2012 Jul 2. PubMed PMID: 22753481; PubMed Central PMCID: PMC3420192.

Montero A, Gastaminza P, Law M, Cheng G, Chisari FV, Ghadiri MR. Self-assembling peptide nanotubes with antiviral activity against hepatitis C virus. Chem Biol. 2011 Nov 23;18(11):1453-62. PubMed PMID: 22118679; PubMed Central PMCID: PMC3225806.

Chisari FV, García-Sastre A. Pioneers of pathogenesis: past and present. Curr Opin Virol. 2011 Sep;1(3):157-9. Epub 2011 Jul 23. PubMed PMID: 22440715.

Dreux M, Chisari FV. Impact of the autophagy machinery on hepatitis C virus infection. Viruses. 2011 Aug;3(8):1342-57. Epub 2011 Aug 4. Review. PubMed PMID: 21994783; PubMed Central PMCID: PMC3185811.

Sitia G, Iannacone M, Aiolfi R, Isogawa M, van Rooijen N, Scozzesi C, Bianchi ME, von Andrian UH, Chisari FV, Guidotti LG. Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis. PLoS Pathog. 2011 Jun;7(6):e1002061. doi: 10.1371/journal.ppat.1002061. Epub 2011 Jun 2. PubMed PMID: 21655107; PubMed Central PMCID: PMC3107209.

Gastaminza P, Pitram SM, Dreux M, Krasnova LB, Whitten-Bauer C, Dong J, Chung J, Fokin VV, Sharpless KB, Chisari FV. Antiviral stilbene 1,2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infection. J Virol. 2011 Jun;85(11):5513-23. Epub 2011 Mar 23. PubMed PMID: 21430055; PubMed Central PMCID: PMC3094966.

MacPherson JI, Sidders B, Wieland S, Zhong J, Targett-Adams P, Lohmann V, Backes P, Delpuech-Adams O, Chisari F, Lewis M, Parkinson T, Robertson DL. An integrated transcriptomic and meta-analysis of hepatoma cells reveals factors that influence susceptibility to HCV infection. PLoS One. 2011;6(10):e25584. Epub 2011 Oct 25. PubMed PMID: 22046242; PubMed Central PMCID: PMC3201949.

Gastaminza P, Dryden KA, Boyd B, Wood MR, Law M, Yeager M, Chisari FV. Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture. J Virol. 2010 Nov;84(21):10999-1009. Epub 2010 Aug 4. PubMed PMID: 20686033; PubMed Central PMCID: PMC2953183.

Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris). 2010 Aug;58(4):258-66. Epub 2010 Feb 8. Review. PubMed PMID: 20116937; PubMed Central PMCID: PMC2888709.

Chatterji U, Lim P, Bobardt MD, Wieland S, Cordek DG, Vuagniaux G, Chisari F, Cameron CE, Targett-Adams P, Parkinson T, Gallay PA. HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors. J Hepatol. 2010 Jul;53(1):50-6. Epub 2010 Apr 3. PubMed PMID: 20451281; PubMed Central PMCID: PMC2884070.

Takahashi K, Asabe S, Wieland S, Garaigorta U, Gastaminza P, Isogawa M, Chisari FV. Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7431-6. Epub 2010 Mar 15. PubMed PMID: 20231459; PubMed Central PMCID: PMC2867703.

Dreux M, Chisari FV. Viruses and the autophagy machinery. Cell Cycle. 2010 Apr 1;9(7):1295-1307. Review. PubMed PMID: 20305376.

Bissig KD, Wieland SF, Tran P, Isogawa M, Le TT, Chisari FV, Verma IM. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest. 2010 Mar;120(3):924-30. doi: 10.1172/JCI40094. Epub 2010 Feb 22. PubMed PMID: 20179355; PubMed Central PMCID: PMC2827952.

Bandi P, Garcia ML, Booth CJ, Chisari FV, Robek MD. Bortezomib inhibits hepatitis B virus replication in transgenic mice. Antimicrob Agents Chemother. 2010 Feb;54(2):749-56. Epub 2009 Nov 30. PubMed PMID: 19949053; PubMed Central PMCID: PMC2812171.

Yang PL, Althage A, Chung J, Maier H, Wieland S, Isogawa M, Chisari FV. Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):798-802. Epub 2009 Dec 22. PubMed PMID: 20080755; PubMed Central PMCID: PMC2818933.

Gastaminza P, Whitten-Bauer C, Chisari FV. Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection. Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):291-6. Epub 2009 Dec 7. PubMed PMID: 19995961; PubMed Central PMCID: PMC2806752.

Garaigorta U, Chisari FV. Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe. 2009 Dec 17;6(6):513-22. PubMed PMID: 20006840; PubMed Central PMCID: PMC2905238.

Dreux M, Chisari FV. Autophagy proteins promote hepatitis C virus replication. Autophagy. 2009 Nov;5(8):1224-5. Epub 2009 Nov 1. PubMed PMID: 19844160.

Asabe S, Wieland SF, Chattopadhyay PK, Roederer M, Engle RE, Purcell RH, Chisari FV. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J Virol. 2009 Oct;83(19):9652-62. Epub 2009 Jul 22. PubMed PMID: 19625407; PubMed Central PMCID: PMC2748002.

Dreux M, Gastaminza P, Wieland SF, Chisari FV. The autophagy machinery is required to initiate hepatitis C virus replication. Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14046-51. Epub 2009 Aug 3. PubMed PMID: 19666601; PubMed Central PMCID: PMC2729017.

Bukh J, Thimme R, Meunier JC, Faulk K, Spangenberg HC, Chang KM, Satterfield W, Chisari FV, Purcell RH. Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain. J Virol. 2008 Aug;82(16):8183-95. Epub 2008 Jun 11. PubMed PMID: 18550671; PubMed Central PMCID: PMC2519567.

Bobardt MD, Cheng G, de Witte L, Selvarajah S, Chatterji U, Sanders-Beer BE, Geijtenbeek TB, Chisari FV, Gallay PA. Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus. Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5525-30. Epub 2008 Mar 31. PubMed PMID: 18378908; PubMed Central PMCID: PMC2291127.

Gastaminza P, Cheng G, Wieland S, Zhong J, Liao W, Chisari FV. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol. 2008 Mar;82(5):2120-9. Epub 2007 Dec 12. PubMed PMID: 18077707; PubMed Central PMCID: PMC2258938.

Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV. A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93. Epub 2008 Feb 19. PubMed PMID: 18287023; PubMed Central PMCID: PMC2268589.

Iannacone M, Sitia G, Isogawa M, Whitmire JK, Marchese P, Chisari FV, Ruggeri ZM, Guidotti LG. Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus. Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):629-34. Epub 2008 Jan 9. PubMed PMID: 18184798; PubMed Central PMCID: PMC2206587.

Law M, Maruyama T, Lewis J, Giang E, Tarr AW, Stamataki Z, Gastaminza P, Chisari FV, Jones IM, Fox RI, Ball JK, McKeating JA, Kneteman NM, Burton DR. Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat Med. 2008 Jan;14(1):25-7. Epub 2007 Dec 6. PubMed PMID: 18064037.

Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature. 2007 Oct 18;449(7164):919-22. PubMed PMID: 17943132; PubMed Central PMCID: PMC2748825.

Sidney J, Peters B, Moore C, Pencille TJ, Ngo S, Masterman KA, Asabe S, Pinilla C, Chisari FV, Sette A. Characterization of the peptide-binding specificity of the chimpanzee class I alleles A 0301 and A 0401 using a combinatorial peptide library. Immunogenetics. 2007 Sep;59(9):745-51. Epub 2007 Aug 16. PubMed PMID: 17701407.

Sakai A, Takikawa S, Thimme R, Meunier JC, Spangenberg HC, Govindarajan S, Farci P, Emerson SU, Chisari FV, Purcell RH, Bukh J. In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells. J Virol. 2007 Jul;81(13):7208-19. Epub 2007 Apr 4. PubMed PMID: 17409145; PubMed Central PMCID: PMC1933310.

Cheng G, Zhong J, Chung J, Chisari FV. Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proc Natl Acad Sci U S A. 2007 May 22;104(21):9035-40. Epub 2007 May 15. PubMed PMID: 17517627; PubMed Central PMCID: PMC1885623.

Maier H, Isogawa M, Freeman GJ, Chisari FV. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J Immunol. 2007 Mar 1;178(5):2714-20. PubMed PMID: 17312113.

Robek MD, Garcia ML, Boyd BS, Chisari FV. Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus. J Virol. 2007 Jan;81(2):483-91. Epub 2006 Nov 1. PubMed PMID: 17079320; PubMed Central PMCID: PMC1797445.

Kapadia SB, Barth H, Baumert T, McKeating JA, Chisari FV. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J Virol. 2007 Jan;81(1):374-83. Epub 2006 Oct 18. PubMed PMID: 17050612; PubMed Central PMCID: PMC1797271.

Gastaminza P, Kapadia SB, Chisari FV. Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J Virol. 2006 Nov;80(22):11074-81. Epub 2006 Sep 6. PubMed PMID: 16956946; PubMed Central PMCID: PMC1642172.

Zhong J, Gastaminza P, Chung J, Stamataki Z, Isogawa M, Cheng G, McKeating JA, Chisari FV. Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J Virol. 2006 Nov;80(22):11082-93. Epub 2006 Sep 6. PubMed PMID: 16956932; PubMed Central PMCID: PMC1642175.

Uprichard SL, Chung J, Chisari FV, Wakita T. Replication of a hepatitis C virus replicon clone in mouse cells. Virol J. 2006 Oct 28;3:89. PubMed PMID: 17069661; PubMed Central PMCID: PMC1635043.

Sainz B Jr, Chisari FV. Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells. J Virol. 2006 Oct;80(20):10253-7. PubMed PMID: 17005703; PubMed Central PMCID: PMC1617281.

Sidney J, Asabe S, Peters B, Purton KA, Chung J, Pencille TJ, Purcell R, Walker CM, Chisari FV, Sette A. Detailed characterization of the peptide binding specificity of five common Patr class I MHC molecules. Immunogenetics. 2006 Jul;58(7):559-70. Epub 2006 Jun 22. PubMed PMID: 16791621.

Dryden KA, Wieland SF, Whitten-Bauer C, Gerin JL, Chisari FV, Yeager M. Native hepatitis B virions and capsids visualized by electron cryomicroscopy. Mol Cell. 2006 Jun 23;22(6):843-50. PubMed PMID: 16793552.

Cheng G, Zhong J, Chisari FV. Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. Proc Natl Acad Sci U S A. 2006 May 30;103(22):8499-504. Epub 2006 May 17. PubMed PMID: 16707574; PubMed Central PMCID: PMC1482521.

Kimura K, Moriwaki H, Nagaki M, Saio M, Nakamoto Y, Naito M, Kuwata K, Chisari FV. Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease. Am J Pathol. 2006 Mar;168(3):786-95. PubMed PMID: 16507894; PubMed Central PMCID: PMC1606511.

Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol. 2006;1:23-61. Review. PubMed PMID: 18039107.

Murray JM, Wieland SF, Purcell RH, Chisari FV. Dynamics of hepatitis B virus clearance in chimpanzees. Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17780-5. Epub 2005 Nov 23. PubMed PMID: 16306261; PubMed Central PMCID: PMC1345724.

Iannacone M, Sitia G, Isogawa M, Marchese P, Castro MG, Lowenstein PR, Chisari FV, Ruggeri ZM, Guidotti LG. Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med. 2005 Nov;11(11):1167-9. Epub 2005 Oct 30. PubMed PMID: 16258538; PubMed Central PMCID: PMC2908083.

Gilbert RJ, Beales L, Blond D, Simon MN, Lin BY, Chisari FV, Stuart DI, Rowlands DJ. Hepatitis B small surface antigen particles are octahedral. Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14783-8. Epub 2005 Oct 3. PubMed PMID: 16203986; PubMed Central PMCID: PMC1253561.

Chisari FV. Unscrambling hepatitis C virus-host interactions. Nature. 2005 Aug 18;436(7053):930-2. PubMed PMID: 16107831.

Wieland SF, Chisari FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol. 2005 Aug;79(15):9369-80. Review. PubMed PMID: 16014900; PubMed Central PMCID: PMC1181548.

Wieland SF, Eustaquio A, Whitten-Bauer C, Boyd B, Chisari FV. Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9913-7. Epub 2005 Jul 1. PubMed PMID: 15994231; PubMed Central PMCID: PMC1175012.

Isogawa M, Furuichi Y, Chisari FV. Oscillating CD8(+) T cell effector functions after antigen recognition in the liver. Immunity. 2005 Jul;23(1):53-63. PubMed PMID: 16039579.

Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9294-9. Epub 2005 Jun 6. PubMed PMID: 15939869; PubMed Central PMCID: PMC1166622.

Isogawa M, Robek MD, Furuichi Y, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol. 2005 Jun;79(11):7269-72. PubMed PMID: 15890966; PubMed Central PMCID: PMC1112123.

Bui HH, Sidney J, Peters B, Sathiamurthy M, Sinichi A, Purton KA, Mothé BR, Chisari FV, Watkins DI, Sette A. Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics. 2005 Jun;57(5):304-14. Epub 2005 May 3. PubMed PMID: 15868141.

Isogawa M, Kakimi K, Kamamoto H, Protzer U, Chisari FV. Differential dynamics of the peripheral and intrahepatic cytotoxic T lymphocyte response to hepatitis B surface antigen. Virology. 2005 Mar 15;333(2):293-300. PubMed PMID: 15721363.

Robek MD, Boyd BS, Chisari FV. Lambda interferon inhibits hepatitis B and C virus replication. J Virol. 2005 Mar;79(6):3851-4. PubMed PMID: 15731279; PubMed Central PMCID: PMC1075734.

Chen M, Sällberg M, Hughes J, Jones J, Guidotti LG, Chisari FV, Billaud JN, Milich DR. Immune tolerance split between hepatitis B virus precore and core proteins. J Virol. 2005 Mar;79(5):3016-27. PubMed PMID: 15709022; PubMed Central PMCID: PMC548461.

Kapadia SB, Chisari FV. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2561-6. Epub 2005 Feb 7. PubMed PMID: 15699349; PubMed Central PMCID: PMC549027.

Neumann-Haefelin C, Blum HE, Chisari FV, Thimme R. T cell response in hepatitis C virus infection. J Clin Virol. 2005 Feb;32(2):75-85. Review. PubMed PMID: 15653409.

Links

Chisari bibliography

Chisari patents